Bicycle Therapeutics
Claire McCarthy serves as the Senior Director of Regulatory Affairs CMC at Bicycle Therapeutics since June 2022, following a tenure as International Regulatory Affairs Director at AstraZeneca from January 2020 to June 2022. Prior experience includes roles as Regulatory Affairs Senior Manager CMC and Regulatory Affairs Manager CMC at Amgen from July 2010 to December 2019, and Principal Regulatory Executive at GlaxoSmithKline from May 2009 to July 2010. Claire's career began at the Irish Medicines Board, where responsibilities included Executive Pharmaceutical Assessor and Pharmaceutical Assessor from September 2005 to April 2009. Claire earned a Bachelor of Science in Pharmacy from Trinity College Dublin between 1999 and 2003.
This person is not in any teams
This person is not in any offices
Bicycle Therapeutics
2 followers
Bicycle is pioneering a new class of therapies based on its bicyclic peptide platform.